2002Unpublished venueRequires access

The Comparison of Curative Effect of Mitoxantrone and Daunorubicin on 56 Case of Acute Myeloid Leukemia

Yue Xi

Open publisher page 0 citations

Abstract

Objective To estimate the effect difference between effects of which mitoxantrone and daunorubicin on acute myeloid leukemia.Methods 56 inpatients diagnosed as previous acute myeloid leukonia between july 1993 to December 1999,were randomized either to mitoxantrone trioxide(26)or to daunorubicin(30)Results complete response rate in the two groups of patients were 65.4% and 60.0% respectively;while the partial response rate were 19.2% and 26.7%respectively 2 patients were in the group ofmitoxantrone died early;1 patient was in the group of daunorubicin died early.The main side-effect of mitoxantrone was bone marrow deprssion.The non-bone marrow side-effect was apparently harmful to the liver. Conclusion The curative effect of mitoxantrone and daunorubicin in chemotherapy to treat acute myeloid leukemia was alike.

About this research paper

What this paper is about

Objective To estimate the effect difference between effects of which mitoxantrone and daunorubicin on acute myeloid leukemia.Methods 56 inpatients diagnosed as previous acute myeloid leukonia between july 1993 to December 1999,were randomized either to mitoxantrone trioxide(26)or to daunorubicin(30)Results complete response rate in the two groups of patients were 65.4% and 60.0% respectively;while the partial response rate were 19.2% and 26.7%respectively 2 patients were in the group ofmitoxantrone died early;1 patient was in the group of daunorubicin died early.The main side-effect of mitoxantrone was bone marrow deprssion.The non-bone marrow side-effect was apparently harmful to the liver. Conclusion The curative effect of mitoxantrone and daunorubicin in chemotherapy to treat acute myeloid leukemia was alike.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To estimate the effect difference between effects of which mitoxantrone and daunorubicin on acute myeloid leukemia.Methods 56 inpatients diagnosed as previous acute myeloid leukonia between july 1993 to December 1999,were randomized either to mitoxantrone trioxide(26)or to daunorubicin(30)Results complete response rate in the two groups of patients were 65.4% and 60.0% respectively;while the partial response rate were 19.2% and 26.7%respectively 2 patients were in the group ofmitoxantrone died early;1 patient was in the group of daunorubicin died early.The main side-effect of mitoxantrone was bone marrow deprssion.The non-bone marrow side-effect was apparently harmful to the liver. Conclusion The curative effect of mitoxantrone and daunorubicin in chemotherapy to treat acute myeloid leukemia was alike.

Key concepts: Mitoxantrone, Daunorubicin, Medicine, Myeloid leukemia, Bone marrow, Leukemia, Acute leukemia, Chemotherapy

Related papers

Back to paper searchBrowse research topicsOriginal source
The Comparison of Curative Effect of Mitoxantrone and Daunorubicin on 56 Case of Acute Myeloid Leukemia — Research Paper | ScholarLens